facebook

Second Opinion on a ‘Suspicious’ Eye Freckle: Differentiating Naevus from Choroidal Melanoma

1 min read

Borderline choroidal lesions exist: a small melanoma can resemble a benign naevus, especially early. Differentiation depends on synthesis of history, examination, and multimodal imaging. ¹ ²

Features that increase suspicion include:

  • Thickness above 2 millimetres ¹
  • Subretinal fluid
  • Orange pigment/lipofuscin ³
  • Symptoms (blur, distortion, scotoma)
  • Margin near the optic disc
  • Concerning ultrasound characteristics

A second opinion is appropriate if a lesion is labelled “suspicious” without clear evidence, if imaging is incomplete, or if the follow-up plan is unclear. Reassessment often involves repeating baseline tests, comparing prior images, and documenting risk features explicitly. ²

The goal is not to alarm patients; it is to ensure that classification is correct and that management matches risk. When uncertainty persists, ocular oncology input is the safest pathway. ³

References

  1. Shields CL, Demirci H, Materin MA, Marr BP, Mashayekhi A, Shields JA. Clinical factors in the identification of small choroidal melanoma. Canadian Journal of Ophthalmology. 2004;39(4):351-357. doi:10.1016/S0008-4182(04)80005-X. PMID: 15327099.
  2. Shields CL, Furuta M, Berman EL, Zahler JD, Hoberman DM, Dinh DH, et al. Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases. Archives of Ophthalmology. 2009;127(8):981-987. doi:10.1001/archophthalmol.2009.151. PMID: 19667334.
  3. Dalvin LA, Shields CL, Lally SE, Huang X, Ancona-Lezama D, Williams BK Jr, et al. Combination of multimodal imaging features predictive of choroidal nevus transformation into melanoma. British Journal of Ophthalmology. 2019;103(10):1441-1447. doi:10.1136/bjophthalmol-2018-312967. PMID: 30523045.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.